Nagtegaal I - Search Results

1

Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.

Koopman M, Venderbosch S, van Tinteren H, Ligtenberg MJ, Nagtegaal I, Van Krieken JH, Punt CJ. Koopman M, et al. Among authors: nagtegaal i. Eur J Cancer. 2009 Jul;45(11):1999-2006. doi: 10.1016/j.ejca.2009.04.017. Epub 2009 May 18. Eur J Cancer. 2009. PMID: 19457654

2

Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?

Bus PJ, Nagtegaal ID, Verspaget HW, Lamers CB, Geldof H, Van Krieken JH, Griffioen G. Bus PJ, et al. Among authors: nagtegaal id. Aliment Pharmacol Ther. 1999 Nov;13(11):1397-402. doi: 10.1046/j.1365-2036.1999.00652.x. Aliment Pharmacol Ther. 1999. PMID: 10571594 Free article. Clinical Trial.

3

Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers.

Nagtegaal ID, Kranenbarg EK, Hermans J, van de Velde CJ, van Krieken JH. Nagtegaal ID, et al. J Clin Oncol. 2000 Apr;18(8):1771-9. doi: 10.1200/JCO.2000.18.8.1771. J Clin Oncol. 2000. PMID: 10764439 Free article.

4

No downstaging after short-term preoperative radiotherapy in rectal cancer patients.

Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, van Krieken JH; Pathology Review Committee and the Cooperative Clinical Investigators. Marijnen CA, et al. Among authors: nagtegaal id. J Clin Oncol. 2001 Apr 1;19(7):1976-84. doi: 10.1200/JCO.2001.19.7.1976. J Clin Oncol. 2001. PMID: 11283130 Free article. Clinical Trial.

5

Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study.

Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van Krieken JH. Nagtegaal ID, et al. BMC Cancer. 2001;1:7. doi: 10.1186/1471-2407-1-7. Epub 2001 Jul 16. BMC Cancer. 2001. PMID: 11481031 Free PMC article.

6

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group. Kapiteijn E, et al. Among authors: nagtegaal id. N Engl J Med. 2001 Aug 30;345(9):638-46. doi: 10.1056/NEJMoa010580. N Engl J Med. 2001. PMID: 11547717 Free article. Clinical Trial.

7

p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.

Marijnen CA, Kapiteijn E, Nagtegaal ID, Mulder-Stapel AA, van de Velde CJ, Schrier PI, Peltenburg LT, van Krieken JH. Marijnen CA, et al. Among authors: nagtegaal id. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):720-8. doi: 10.1016/s0360-3016(01)02674-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 11849795 Clinical Trial.

8

Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH; Pathology Review Committee; Cooperative Clinical Investigators. Nagtegaal ID, et al. Am J Surg Pathol. 2002 Mar;26(3):350-7. doi: 10.1097/00000478-200203000-00009. Am J Surg Pathol. 2002. PMID: 11859207 Clinical Trial.

9

Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.

Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Nagtegaal ID, et al. J Clin Oncol. 2002 Apr 1;20(7):1729-34. doi: 10.1200/JCO.2002.07.010. J Clin Oncol. 2002. PMID: 11919228 Free article. Clinical Trial.

10

The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview.

Nagtegaal ID, van Krieken JH. Nagtegaal ID, et al. Eur J Cancer. 2002 May;38(7):964-72. doi: 10.1016/s0959-8049(02)00056-4. Eur J Cancer. 2002. PMID: 11978521 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

430 results

Search Page